Leclerc, Jacinthe
Blais, Claudia
Rochette, Louis
Hamel, Denis
Guénette, Line
Poirier, Paul
Article History
First Online: 10 May 2019
Compliance with Ethical Standards
:
: There was no funding for this study, part of the continuous chronic disease surveillance mandate in the province of Quebec, Canada.
: Paul Poirier has received honoraria for continuing medical education/consultant/expert events from Abbott Vascular, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, NovoNordisk, Pfizer, Roche, Sanofi-Aventis, Servier and Valeant. The industry had no influence in any decisions made through this project. Jacinthe Leclerc, Claudia Blais, Louis Rochette, Denis Hamel and Line Guénette have no conflict of interest relevant to the content of this article.
: Protocol design: Jacinthe Leclerc, Paul Poirier, Claudia Blais, Line Guénette, Denis Hamel and Louis Rochette. Data acquisition, analysis: Louis Rochette, Denis Hamel and Jacinthe Leclerc. Interpretation of data: Jacinthe Leclerc, Paul Poirier, Claudia Blais, Line Guénette, Denis Hamel and Louis Rochette. Drafting of the work: Jacinthe Leclerc. Revisions of critically important intellectual content: Claudia Blais, Line Guénette, Denis Hamel, Louis Rochette and Paul Poirier. Final approval of the version to be published: Paul Poirier. Agreement to be accountable for all aspects of the work: Jacinthe Leclerc, Claudia Blais, Louis Rochette, Denis Hamel, Line Guénette and Paul Poirier.